June 2014 FDA Recall Drug by Mylan Pharmaceuticals Inc.
D-1539-2014 - Failed Impurities/Degradation Specifications; Out of specification for lactol and total impurities.

This Class III drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc. on June 20, 2014 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications; out of specification for lactol and total impurities.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1539-2014

Reason for Recall
Failed Impurities/Degradation Specifications; Out of specification for lactol and total impurities.
Initiated
06-20-2014
Reported
08-27-2014
Quantity
9225 Bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Mylan Pharmaceuticals Inc.
Tolterodine Tartrate Tablets, 1 mg, 60 Tablet Bottles, Rx only. Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-5445-91.

Batch or Lot Expiration Information

Lot# 2004069, Expiry: 09/2014
Lot# : 2004070, Expiry: 09/2014.